Skip to Content

What is Idhifa used to treat?

Answers (1)

Official Answer by Drugs.com 10 Oct 2017

Idhifa (enasidenib), from Celgene Corporation, is used to treat adult patients with relapsed (has returned after initial treatment) or refractory (has not responded to treatment) acute myeloid leukemia (AML) who have a specific genetic mutation. The drug is approved for use with a companion diagnostic, the RealTime IDH2 Assay, which is used to detect specific mutations in the IDH2 gene in patients with AML. IDH2 gene mutations may lead to immature blood cells becoming cancerous and dividing uncontrollably, causing AML.

Votes: +0
Drugs.com free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What is the difference between Biktarvy and Descovy?

Posted 7 Mar 2018 1 answerFAQ by Drugs.com

What is the difference between Symdeko and Orkambi?

Posted 7 Mar 2018 1 answerFAQ by Drugs.com